Compositions and methods for delivery of frozen particle adhesives
원문보기
IPC분류정보
국가/구분
United States(US) Patent
등록
국제특허분류(IPC7판)
A61K-009/00
A61K-009/16
A61K-009/08
A61K-031/00
A61K-051/12
A61K-009/19
A61K-031/10
A61K-031/337
A61K-031/70
A61K-031/7088
A61K-033/00
A61K-041/00
A61K-045/06
A61K-049/18
A61K-039/00
출원번호
US-0383263
(2009-03-20)
등록번호
US-9050251
(2015-06-09)
발명자
/ 주소
Boyden, Edward S.
Cook, Daniel B.
Hyde, Roderick A.
Leuthardt, Eric C.
Myhrvold, Nathan P.
Sweeney, Elizabeth A.
Wood, Jr., Lowell L.
출원인 / 주소
The Invention Science Fund I, LLC
인용정보
피인용 횟수 :
3인용 특허 :
144
초록▼
Certain embodiments disclosed herein relate to compositions, methods, devices, systems, and products regarding frozen particles. In certain embodiments, the frozen particles include materials at low temperatures. In certain embodiments, the frozen particles provide vehicles for delivery of particula
Certain embodiments disclosed herein relate to compositions, methods, devices, systems, and products regarding frozen particles. In certain embodiments, the frozen particles include materials at low temperatures. In certain embodiments, the frozen particles provide vehicles for delivery of particular agents. In certain embodiments, the frozen particles are administered to at least one biological tissue.
대표청구항▼
1. A frozen particle composition, comprising: one or more frozen saline solution particles including at least one adhesive agent substantially in the form of a vesicle and including an acrylic polymer;and wherein the frozen particle composition is externally coated with at least one anesthetic, anal
1. A frozen particle composition, comprising: one or more frozen saline solution particles including at least one adhesive agent substantially in the form of a vesicle and including an acrylic polymer;and wherein the frozen particle composition is externally coated with at least one anesthetic, analgesic, or antimicrobial agent, wherein the analgesic or anesthetic includes at least one of an aminoamid or aminoester local anesthetic, ibuprofen, morphine, codeine, lidocaine/lignocaine, ropivacaine, mepivacaine, benzocaine, chloroprocaine, cyclomethycaine, dimethocaine/larocaine, propoxycaine, procaine/novocaine, proparacaine, tetracaine/amethocaine, articaine, bupivacaine, carticaine, cinchocaine/dibucaine, etidocaine, levobupivacaine, piperocaine, prilocaine, trimecaine, saxitoxin, tetrodotoxin, acetaminophen, a non-steroidal anti-inflammatory drug, salicylate, narcotic, or tramadol; and wherein the antimicrobial agent includes at least one of an anti-fungal agent, antibiotic agent, anti-bacterial agent, anti-parasitic agent, or anti-worm agent. 2. The frozen particle composition of claim 1, wherein the at least one major dimension includes at least one of the radius, diameter, length, width, height, or perimeter. 3. The frozen particle composition of claim 1, wherein the at least one adhesive agent includes at least one of a monomer, prepolymer, polymer, or copolymer. 4. The frozen particle composition of claim 1, further including at least one material that solidifies in situ at physiological temperature and pH. 5. The frozen particle composition of claim 1, wherein one or more bone morphogenic proteins are encapsulated by the vesicle. 6. The frozen particle composition of claim 1, wherein the at least one adhesive agent includes at least one crosslinking or derivatized agent. 7. The frozen particle composition of claim 1, wherein one or more integrin peptides are encapsulated by the vesicle. 8. The frozen particle composition of claim 7, wherein one or more silica beads are encapsulated by the vesicle. 9. The frozen particle composition of claim 1, wherein the at least one adhesive agent includes a methacrylate. 10. The frozen particle composition of claim 8, wherein the at least one adhesive agent includes at least one of poly(N,N-dimethyl-N-(ethoxycarbonylmethyl)-N-[2′-(methacryloyloxy)ethyl]-ammonium bromide) or poly(sulfobetaine methacrylate). 11. The frozen particle composition of claim 1, further including at least one of a nanoparticle, detection material, sensor, micro-syringe, or circuit. 12. The frozen particle composition of claim 11, wherein the detection material includes at least one electronic identification device. 13. The frozen particle composition of claim 12, wherein the at least one electronic identification device includes at least one radio frequency identification device. 14. The frozen particle composition of claim 11, wherein the detection material includes at least one radioactive element. 15. The frozen particle composition of claim 14, wherein the at least one radioactive element includes one or more of 32P, 35S, 13C, 131I, 191Ir, 192Ir, 193Ir, 201Tl, or 3H. 16. The frozen particle composition of claim 11, wherein the detection material includes at least one luminescent, colorimetric, or odorous substance. 17. The frozen particle composition of claim 11, wherein the detection material includes at least one of a diamagnetic particle, ferromagnetic particle, paramagnetic particle, super paramagnetic contrast agent, or other magnetic particle. 18. The frozen particle composition of claim 1, further including one or more explosive materials. 19. The frozen particle composition of claim 18, wherein the one or more explosive materials include at least one of a carbonate, carbon dioxide, nitroglycerine, acid, base, epoxy, acrylic polymer or copolymer, acrylamide polymer or copolymer, urethane, hypoxyapatite, or a reactive metal. 20. The frozen particle composition of claim 1, wherein the at least one adhesive agent is frozen. 21. The frozen particle composition of claim 1, wherein the at least one adhesive agent includes at least one a-cyanoacrylate and a fluorescent compound including at least one of a bis-benzoxazolyl compound, pyrylium salt, quantum dot, or coumarin compound. 22. The frozen particle composition of claim 1, wherein the at least one adhesive agent includes an α-cyanoacrylate and 2,5-bis-(5-tert-butyl-2-benzoxasolyl)-thiophene. 23. The frozen particle composition of claim 1, wherein the at least one adhesive agent further includes one or more of a base component, initiator component, or activator component. 24. The frozen particle composition of claim 1, wherein the at least one adhesive agent further includes at least one curing component. 25. The frozen particle composition of claim 1, wherein the adhesive agent includes at least one dye coinitiator. 26. A method for providing at least one adhesive agent to at least one substrate, comprising: administering at least one frozen particle composition to at least one substrate,wherein the at least one frozen particle composition includes one or more frozen saline solution particles including at least one adhesive agent substantially in the form of a vesicle and including an acrylic polymer;and wherein the frozen particle composition is externally coated with at least one anesthetic, analgesic, or antimicrobial agent, wherein the analgesic or anesthetic includes at least one of an aminoamid or aminoester local anesthetic, ibuprofen, morphine, codeine, lidocaine/lignocaine, ropivacaine, mepivacaine, benzocaine, chloroprocaine, cyclomethycaine, dimethocaine/larocaine, propoxycaine, procaine/novocaine, proparacaine, tetracaine/amethocaine, articaine, bupivacaine, carticaine, cinchocaine/dibucaine, etidocaine, levobupivacaine, piperocaine, prilocaine, trimecaine, saxitoxin, tetrodotoxin, acetaminophen, a non-steroidal anti-inflammatory drug, salicylate, narcotic, or tramadol; and wherein the antimicrobial agent includes at least one of an anti-fungal agent, antibiotic agent, anti-bacterial agent, anti-parasitic agent, or anti-worm agent. 27. The method of claim 26, wherein the at least one frozen particle composition is in at least one crystalline or amorphous phase. 28. The method of claim 26, wherein the at least one adhesive agent is configured to polymerize at or above the temperature of the at least one substrate. 29. The method of claim 26, wherein the at least one adhesive agent is configured to polymerize at or above the temperature of at least one biological tissue. 30. The method of claim 26, wherein the at least one adhesive agent is configured to polymerize at or above the temperature of at least one subject. 31. The method of claim 26, wherein the at least one substrate includes one or more of a cell, tissue, organ, structure, or device. 32. The method of claim 31, wherein the structure includes one or more of a prosthesis, cell matrix, or tissue matrix. 33. The method of claim 31, wherein the device includes at least one mechanical or electrical device. 34. The method of claim 26, wherein the at least one substrate includes at least one implantable substrate. 35. The method of claim 26, wherein the at least substrate includes at least one cell mass. 36. The method of claim 26, wherein the at least one substrate includes one or more wounds. 37. The method of claim 36, wherein the one or more wounds are located in at least one biological tissue including at least one of skin tissue, muscle tissue, eye tissue, an organ, connective tissue, fetal tissue, nervous tissue, peritoneal tissue, neoplastic tissue, or bone tissue. 38. The method of claim 26, wherein administering at least one frozen particle composition to at least one substrate includes accelerating, propelling, or ejecting the frozen particle composition toward the at least one substrate. 39. The method of claim 26, further including varying the rate, velocity, or angle at which the at least one frozen particle composition is administered to at least one substrate. 40. The method of claim 26, further including a plurality of frozen particle compositions, wherein two or more of the plurality of frozen particle compositions include two or more adhesive agents are configured to physically or chemically bind upon administration. 41. The method of claim 26, further including administering to the at least one substrate at least one of a nanoparticle, detection material, sensor, micro-syringe, or circuit. 42. The method of claim 26, wherein the at least one adhesive agent includes a detectable state that varies with its adhesive state. 43. The method of claim 26, wherein the at least one adhesive agent further includes one or more of a base component, initiator component, or activator component. 44. The method of claim 26, wherein the at least one adhesive agent further includes at least one curing component. 45. The method of claim 26, wherein the adhesive agent includes at least one dye coinitiator. 46. A method of maintaining the approximation of tissue of the at least one wound of a subject, comprising: administering at least one frozen particle composition to at least one wound of a subject for a time sufficient to maintain the approximation of tissue of the at least one wound;wherein the at least one frozen particle composition includes one or more frozen saline solution particles including at least one adhesive agent substantially in the form of a vesicle and including an acrylic polymer;and wherein the frozen particle composition is externally coated with at least one anesthetic, analgesic, or antimicrobial agent, wherein the analgesic or anesthetic includes at least one of an aminoamid or aminoester local anesthetic, ibuprofen, morphine, codeine, lidocaine/lignocaine, ropivacaine, mepivacaine, benzocaine, chloroprocaine, cyclomethycaine, dimethocaine/larocaine, propoxycaine, procaine/novocaine, proparacaine, tetracaine/amethocaine, articaine, bupivacaine, carticaine, cinchocaine/dibucaine, etidocaine, levobupivacaine, piperocaine, prilocaine, trimecaine, saxitoxin, tetrodotoxin, acetaminophen, a non-steroidal anti-inflammatory drug, salicylate, narcotic, or tramadol; and wherein the antimicrobial agent includes at least one of an anti-fungal agent, antibiotic agent, anti-bacterial agent, anti-parasitic agent, or anti-worm agent. 47. The method of claim 46, wherein administering at least one frozen particle composition to at least one substrate includes accelerating, propelling, or ejecting the frozen particle composition toward the at least one substrate. 48. The method of claim 46, further including varying the rate, velocity, or angle at which the at least one frozen particle composition is administered to at least one wound. 49. The frozen particle composition of claim 1, wherein the adhesive agent further includes at least one of urethane, gum Arabic, polyester, polyhydroxyalkanoate, poly(L-lactic acid), polyglycolide, polylactic acid, polyether, polyol, polyvinylpyrrolidone, pyroxylin, polymethylacrylate-isobutene-monoisopropylmaleate, siloxane polymer, polylactic-co-glycolic-acid, poly-3-hydroxybutyrate, poly-4-hydroxybutyrate, polyhydroxyvalerate, polydydroxyhexanoate, polydyroxyoctanoate, polycaprolactone, poly (e-caprolactone), sialyl Lewisx, heme group, hemoglobin, healon, carboxymethylcellulose, silicone, cadherin, integrin, hydroxyapatite, polyelectrolyte, maleic polyelectrolyte, cellulose, resilin, cyanoacrylate, isocyanate, 2-octyl cyanoacrylate, 2-butyl-n-cyanoacrylate, n-butyl-2-cyanoacrylate, butyl-2-cyanoacrylate, methyl 2-cyanoacrylate, polyisohexylcyanoacrylate, fibrin, thrombin, fibrinogen, hyaluronate, chitin, Factor XIII, Factor XII, silk, nylon, collagen, glycosaminoglycan, selectin, polyurethane, methacrylate, polysulfide, polyanhydride, polydioxanone, poly-p-dioxanone, albumin, glutaraldehyde, or polyethylene glycol. 50. The frozen particle composition of claim 1, wherein the frozen solution of saline in water further includes a surfactant in the frozen solution. 51. The frozen particle composition of claim 1, further including at least one anti-inflammatory agent. 52. The frozen particle composition of claim 1, further including at least one angiogenic factor. 53. The frozen particle composition of claim 1, further including at least one cytokine. 54. The frozen particle composition of claim 1, further including at least one coagulant. 55. The frozen particle composition of claim 1, further including at least one cytotoxic agent. 56. A frozen particle composition, comprising: one or more frozen salt buffer solution particles containing at least one acrylic polymer substantially in the form of a vesicle and encapsulating at least one antibody;wherein the one or more frozen salt buffer solution particles are a frozen solution in particle form of at least one salt buffer including TRIS-buffered saline, standard saline citrate, HEPES-buffered saline, Ringer's solution, lactated Ringer's solution, Hank's balanced salt solution, Earle's balanced salt solution, Hartmann's solution, HEPES buffer, or phosphate buffered solution, and further include zinc oxide powder and phosphoric acid; andwherein the frozen salt buffer solution particles have at least one major dimension of approximately one micrometer or less, approximately one nanometer or less, or any value therebetween. 57. The frozen particle composition of claim 56, further including methyl methacrylate and polymethyl methacrylate. 58. The frozen particle composition of claim 56, further including at least one cytotoxic agent. 59. A frozen particle composition, comprising: one or more frozen dimethyl sulfoxide solution particles containing at least one adhesive agent of acrylic polymer, polylactic acid, poly (L-lactic acid), polyethylene glycol, polyol, polyether, polyol, polyvinylpyrrolidone, pyroxylin, polymethylacrylate-isobutene-monoisopropylmaleate, siloxane polymer, polylactic-co-glycolic-acid, poly-3-hydroxybutyrate, poly-4-hydroxybutyrate, polyhydroxyvalerate, polydydroxyhexanoate, polydyroxyoctanoate, polycaprolactone, poly (e-caprolactone), sialyl Lewisx, heme group, hemoglobin, healon, carboxymethylcellulose, hydroxyapatite, silicone, cadherin, integrin, polyelectrolyte, maleic polyelectrolyte, cellulose, resilin, cyanoacrylate, isocyanate, 2-octyl cyanoacrylate, 2-butyl-n-cyanoacrylate, n-butyl-2-cyanoacrylate, butyl-2-cyanoacrylate, methyl 2-cyanoacrylate, polyisohexylcyanoacrylate, fibrin, thrombin, fibrinogen, hyaluronate, chitin, Factor XIII, Factor XII, silk, nylon, collagen, glycosaminoglycan, selectin, polyurethane, methacrylate, polysulfide, polyanhydride, polydioxanone, poly-p-dioxanone, albumin, glutaraldehyde or gelatin substantially in the form of a vesicle and encapsulating at least one stem cell;one or more reinforcement agents of kaolin, or cellulose;wherein the one or more frozen dimethyl sulfoxide solution particles are a frozen solution of dimethyl sulfoxide, and wherein the frozen dimethyl sulfoxide solution particles have at least one major dimension of approximately one micrometer or less, approximately one nanometer or less, or any value therebetween. 60. The frozen composition of claim 59, wherein the frozen dimethyl sulfoxide solution particles further include at least one coagulant, anti-coagulant, anesthetic, antimicrobial agent, anti-inflammatory, or analgesic.
연구과제 타임라인
LOADING...
LOADING...
LOADING...
LOADING...
LOADING...
이 특허에 인용된 특허 (144)
Phillips William T. (San Antonio TX) Klipper Robert W. (San Antonio TX) Timmons James H. (Tacoma WA) Rudolph Alan S. (Bowie MD), 99m TC labeled liposomes.
Smits Georges (Gijzegem-Aalst BEX) Daenekindt Luc (Gijzegem-Aalst BEX) Booten Karl (Geetbets BEX), Agglomerated composition, process for producing it and food products containing the said composition.
Armstrong Jay (1543 Weymouth Cir. ; Apt. 109 Westlake OH 44145) Becker James R. (6272 Mills Creek La. North Ridgeville OH 44039), Blast cleaning system.
Topalian Harry H. (Dover DE) Wyss Clement R. (Lewes DE) Kenyon Ralph E. (Dover DE) Dec Anthony F. (Dover DE), Frozen aerated ready-to-eat gelatin composition.
Brinegar Chris (587 Locksley Rd. Boulder Creek CA 95006) Gilmore James (6385 Camino Verde Dr. San Jose CA 95119) Johnson Michael (6385 Camino Verde Dr. San Jose CA 95119) Walker Nigel (5385 Broadway , Ice-mediated introduction of substances into biological material.
Thomas Dag Horn ; Sandra Marchese Johnson, Immunotherapy of epithelial tumors using intralesional injection of antigens that induce a delayed type hypersensitivity reaction.
Rahman Aquilur (Gaithersburg MD) Rafaeloff Rafael (Tel-Aviv MD ILX) Husain Syed R. (Gaithersburg MD), Liposome encapsulated taxol and a method of using the same.
Weaver, James C.; Anderson, R. Rox; Herndon, Terry O; Gowrishankar, T. R.; Gift, Elizabeth A.; Gonzalez, Salvador, Localized molecular and ionic transport to and from tissues.
Poulsen, Jens Ulrik; Christensen, Lars Hofmann; Aasmul, S.o slashed.ren, Method and a system for assisting a user in a medical self treatment, said self treatment comprising a plurality of actions.
Power Wendy ; Reed Michael A. ; Frustaci Dominick J. ; Larocque Gerald ; Marchetti Brenda, Method and apparatus for determining quantity of liquid in a container and/or lack of motion thereof.
Westergaard Knud E. (Rolighedsvej 16 9560 Hadsund DKX), Method and apparatus for particle blasting using particles of a material that changes its state.
Frohlich, Hans; Gebhardt, Sabine; Trampusch, Berthold, Method and device for generating a two-phase gas-particle jet, in particular containing CO2 dry ice particles.
Cates Michael C. (Solana Beach CA) Hamm Richard R. (San Diego CA) Lewis Michael W. (Wichita KS) Schmitz Wayne N. (St. Louis MO), Method and system for removing a coating from a substrate using radiant energy and a particle stream.
Costantino Henry R. ; Jaworowicz Warren E. ; Tracy Mark A. ; Beganski Christopher P., Method of producing sub-micron particles of biologically active agents and uses thereof.
Cummins Thomas J. (Rochester NY) Ekeze Tobias D. (Rochester NY), Methods of extracting nucleic acids and PCR amplification without using a proteolytic enzyme.
Rhim Won-Kyu (Pasadena CA) Hyson Michael T. (Glendale CA) Chung Sang-Kun (Diamond Bar CA) Colvin Michael S. (Malibu CA) Chang Manchium (Los Angeles CA), Monodisperse, polymeric microspheres produced by irradiation of slowly thawing frozen drops.
Shih, Hong; Leonte, Oana M.; Daugherty, John E.; Huang, Tuochuan; Goldspring, Gregory J.; May, Michael C., On-line chamber cleaning using dry ice blasting.
Clark ; Jr. William G. (Murrysville PA) Herald John J. (Monroeville PA) Liaw Peter K. (Knoxville TN), Pressurized ferrofluid paint removal system using an electromagnet and eddy current encircling coil to adjust weight per.
Fages Jacques,FRX ; Marty Alain,FRX ; Combes Didier,FRX ; Condoret Jean-Stephane,FRX, Process for treating bone tissue and corresponding implantable biomaterials.
Clauss Steven L. (Manville NJ) Pastel Michael J. (Highland Mills NY) Zawadzki Rainer K. (Wuhan CNX), Stable porfimer sodium compositions and methods for their manufacture.
Boyden, Edward S.; Cook, Daniel B.; Hyde, Roderick A.; Leuthardt, Eric C.; Myhrvold, Nathan P.; Sweeney, Elizabeth A.; Wood, Jr., Lowell L., Systems, devices, and methods for making or administering frozen particles.
Santa Cruz Cathy D. ; Deniston-Korgol Christine L. ; Baugh Barbara I. ; Baugh Alexandria D. ; Baugh Roger D., Weather-proof wrist, forearm, and elbow protectors.
Dean ; Jr. Robert C. (Norwich VT) Silver Frederick H. (Long Valley NJ) Berg Richard A. (Lambertville NJ) Phillips Philip G. (Norwich VT) Runstadler ; Jr. Peter W. (Hanover NH), Weighted collagen microsponge for immobilizing bioactive material.
Kung, Harold H.; Shen, Jingmei; Kung, Mayfair C.; Hayner, Cary M., Polymer functionalized graphene oxide and thermally responsive ion permeable membranes made therefrom.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.